2023-08-21 15:58:31 ET
More on Eli Lilly
- Eli Lilly Q2: Dividends Don't Lie
- Eli Lilly: Q2 And 2023 Revised Guidance Impressive, But Key Is Wegovy Data
- Eli Lilly and Co ( LLY ) Q2 2023 Earnings Call Transcript
- Eli Lilly Remains A Buy With Strong Sales And Possible Upside With Mounjaro
- Coatue Management takes new stake in Oracle, exits GameStop, trims Tesla, adds to Amazon
- Tiger Global reduces holdings in tech, boosts stakes in Grab, Apollo, adds Eli Lilly
- Eli Lilly closes Sigilon, Versanis buyouts boosting diabetes/ obesity franchise
- Eli Lilly upgraded at Jefferies on Mounjaro sales and Wegovy data (update)
- Seeking Alpha’s Quant Rating on Eli Lilly
- Earnings data for Eli Lilly
- Dividend scorecard for Eli Lilly
For further details see:
Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk